KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Other Non-Current Assets (2018 - 2025)

Historic Other Non-Current Assets for Aurinia Pharmaceuticals (AUPH) over the last 8 years, with Q3 2025 value amounting to $93000.0.

  • Aurinia Pharmaceuticals' Other Non-Current Assets fell 8928.57% to $93000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $93000.0, marking a year-over-year decrease of 8928.57%. This contributed to the annual value of $823000.0 for FY2024, which is 4574.82% down from last year.
  • Per Aurinia Pharmaceuticals' latest filing, its Other Non-Current Assets stood at $93000.0 for Q3 2025, which was down 8928.57% from $93000.0 recorded in Q2 2025.
  • In the past 5 years, Aurinia Pharmaceuticals' Other Non-Current Assets registered a high of $13.4 million during Q1 2023, and its lowest value of $93000.0 during Q2 2025.
  • For the 5-year period, Aurinia Pharmaceuticals' Other Non-Current Assets averaged around $6.4 million, with its median value being $1.5 million (2023).
  • Per our database at Business Quant, Aurinia Pharmaceuticals' Other Non-Current Assets surged by 557272.73% in 2021 and then crashed by 8928.57% in 2025.
  • Quarter analysis of 5 years shows Aurinia Pharmaceuticals' Other Non-Current Assets stood at $11.8 million in 2021, then rose by 12.68% to $13.3 million in 2022, then plummeted by 88.63% to $1.5 million in 2023, then tumbled by 45.75% to $823000.0 in 2024, then plummeted by 88.7% to $93000.0 in 2025.
  • Its last three reported values are $93000.0 in Q3 2025, $93000.0 for Q2 2025, and $823000.0 during Q1 2025.